Approval · Notice of Compliance 1100 · 2000
TENUATE: Notice of Compliance 1100
Issued July 28, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1100
- Date
- July 28, 2000
- Company
- Aventis Pharma Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Anorexiant
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TENUATE | 02047675 | Cancelled Post Market |
| TENUATE DOSPAN | 02052490 | Cancelled Post Market |
Medicinal ingredients
- DIETHYLPROPION HCL 25 MG per TAB
- DIETHYLPROPION HCL 75 MG per TAB